ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 0.1.59 (03 Mar 2017) - 2999001/02758419CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120170419W174deBibliographieenBibliographyfrBibliographieEP12766825.92012092020140317enenen201161537099 P20110921US2017041920171620140730201431201610192016422016032220161019LV20170419201716C07J 63/00 20060101AFI20130408BHEP A61K 31/56 20060101ALI20130408BHEP A61P 31/18 20060101ALI20130408BHEP deNEUE BETULINSÄUREDERIVATE MIT ANTIVIRALER WIRKUNGenNOVEL BETULINIC ACID DERIVATIVES WITH ANTIVIRAL ACTIVITYfrNOUVEAUX DÉRIVÉS D'ACIDE BÉTULINIQUE AYANT UNE ACTIVITÉ ANTIVIRALEWO-A1-2009/100532LIU, Zhengc/o Bristol-Myers Squibb Company 5 Research ParkwayWallingford, CT 06492USMEANWELL, Nicholas A.c/o Bristol-Myers Squibb Company 5 Research ParkwayWallingford, CT 06492USREGUEIRO-REN, Aliciac/o Bristol-Myers Squibb Company 5 Research ParkwayWallingford, CT 06492USVIIV Healthcare UK (No.5) Limited101643379BMS11767980 Great West RoadBrentford, Middlesex TW8 9GSGBLearoyd, Stephanie Anne101323162GlaxoSmithKline Global Patents (CN925.1) 980 Great West RoadBrentford, Middlesex TW8 9GSGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRUS201205618620120920enWO20130437782013032820131320140730201431